NCT05692713View on ClinicalTrials.gov

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

RecruitingOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Chronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemiaBlood CancerNon-Malignant Hematologic and Lymphocytic Disorder
Trial Locations (10)

63130-4899

RECRUITING

Washington University St. Louis, St Louis

68198-5331

RECRUITING

University of Nebraska Medical Center, Omaha

97239-3098

RECRUITING

Oregon Health & Science University, Portland

R3E 0V9

NOT_YET_RECRUITING

CancerCare Manitoba, Winnipeg

B3H 2Y9

NOT_YET_RECRUITING

NS Health, Halifax

L8V 5C2

NOT_YET_RECRUITING

Juravinski Hospital & Cancer Centre, Hamilton

N6C 2R5

NOT_YET_RECRUITING

LHSC: Victoria Hospital, London

M5G 2C4

RECRUITING

UHN Princess Margaret Cancer Centre, Toronto

G1R 2J6

NOT_YET_RECRUITING

CHU de Québec - Université Laval, Laval

H3H 2R9

NOT_YET_RECRUITING

McGill University Health Center, Montreal

All Listed Sponsors
lead

University of British Columbia

OTHER